1.Application of low dose radiation therapy in the treatment of COVID-19 pneumonia
Hui LUO ; Hong GE ; Wenna NIE ; Hui LIU ; Yamei HU ; Wenjuan XU ; Guodong DENG
Chinese Journal of Radiological Medicine and Protection 2021;41(2):151-154
With the global pandemic of COVID-19, cytokine storms in critical patients with pneumonia is really a problem and need to be solved immediately.Low dose radiation therapy (LDRT) has been temporarily used to treat pneumonia.In the past decades, researchers were dedicated to clarify the biological mechanism of LDRT.LDRT plays a unique role in the suppression of inflammation, preliminary outcomes have been acquired in critical patients with COVID-19 pneumonia, and radiotherapy community is paying attention to this treatment strategy.This review summarizes the application of LDRT in pneumonia, its biological mechanism, the result of LDRT in COVID-19 pneumonia, the existing problems and prospective in clinic.
2.Research progresses of the roles of disulfiram in anticancer activity and radiobiology
Hui LUO ; Lili QIAO ; Yonghan LI ; Dandan ZHANG ; Xuechao JIA ; Wenna NIE ; Xiaoli ZHENG ; Yanan SUN ; Chengcheng FAN ; Hong GE
Chinese Journal of Radiological Medicine and Protection 2018;38(8):631-634
Disulfiram (DSF) has been widely used in clinical treatment of alcoholism.To date,in vivo and in vitro experiments have demonstrated that DSF has strong anti-cancer activity and could improve patient's survival,and the underlying mechanism has been elaborated.In addition,it was reported that,during radiotherapy,DSF could protect normal tissue and cells meanwhile enhance the radiosensitivity of tumor cells by forming complexes with copper ions,suppressing cancer stem cells and inhibiting ubiquitin-proteasome system activity in cancer cells.This review summarizes the completed and ongoing clinical trials of disulfiram,and its anti-tumor mechanisms and advances in radiation biology.
3.Effect of mannose on the radiosensitivity of six non-small cell lung cancer cell lines
Hong GE ; Hui LUO ; Kangdong LIU ; Xuechao JIA ; Wenna NIE ; Qiqi ZHANG ; Bingbing LU ; Ran YANG ; Nan WANG ; Shuai SONG ; Ruidi JIAO
Chinese Journal of Radiation Oncology 2020;29(7):558-562
Objective:To investigate the effect of mannose on the radiosensitivity of six human non-small cell lung cancer cell lines and its possible mechanism.Methods:The expression of mannose phosphate isomerase in six lung cancer cell lines were detected by Western blot. The inhibitory effect of mannose on the proliferation of lung cancer cell lines were observed by MTT assay. When irradiated with 0, 2, 4, 6, 8 and 10 Gy, the effect of mannose on the radiosensitivity of six lung cancer cell lines was detected by plate clone formation assay, respectively; and the apoptosis rates of normal control, mannose, irradiation and combined groups were detected by flow cytometry.Results:The expression levels of mannose phosphate isomerase were different among six lung cancer cell lines. Among them, A549 cells had the highest expression level and H460 cells showed the lowest expression level. When aD ministrated with 11.1 mmol/L mannose, the same inhibitory effect was observed on both A549 and H460 cell lines. Moreover, the inhibitory effect on H460 cell line was significantly increased with the increase of mannose concentration. In addition, aD ministration of 11.1 mmol/L mannose could significantly increase the radiosensitivity and apoptosis rate of H460 cell line. However, it exerted limited effect upon the radiosensitivity and apoptosis rate of A549 cell line. Conclusion:In six lung cancer cell lines with high expression of mannose phosphate isomerase, the aD ministration of mannose can enhance the radiosensitivity of partial tumors cells.